Therachon AG , a biotechnology company focused on rare genetic diseases, announced today that Jeffrey Stavenhagen, Ph.D., Vice President Biology, will be presenting at the 2nd Fibroblast Growth Factors in Development and Repair Conference in Cancun, Mexico.
Dr. Stavenhagen will present, "Development of a Novel Biologic for the Treatment of Achondroplasia" on Wednesday, March 8th from 6:35 - 6:55 PM ET. The presentation will take place at the Fiesta Americana Condesa hotel. For more informa
RelSci News & Alerts gets you: